Home › Funds › TWO SIGMA ADVISERS, LP › REGN
TWO SIGMA ADVISERS, LP position in REGN
REGENERON PHARMACEUTICALS · Health Care
TWO SIGMA ADVISERS, LP reported holding 604,540 shares of REGN (REGENERON PHARMACEUTICALS) in its Q4 2025 13F filing — a position valued at US$466.6M, representing 0.91% of its reported portfolio and ranking #22 among its reported holdings. TWO SIGMA ADVISERS, LP has disclosed REGN holdings in 8 of the last 10 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How TWO SIGMA ADVISERS, LP's REGN position evolved
TWO SIGMA ADVISERS, LP first disclosed a stake in REGN in Q3 2023 at 242,900 shares (US$199.9M). The position peaked in Q3 2025 at 926,200 shares, worth US$520.8M. Across 8 filings, TWO SIGMA ADVISERS, LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q4 2025) shows 604,540 shares valued at US$466.6M — a reduction of -321,660 shares quarter over quarter.. Notable position changes include a 95% trim in Q4 2023 (shares rose 10% over the following quarter), a 69% increase in Q2 2025 (shares rose 8% over the following quarter), a 35% trim in Q4 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 242.90K | $199.90M | New |
| Q4 2023 | 12.90K | $11.33M | Reduce |
| Q2 2024 | 1.00K | $1.05M | New |
| Q3 2024 | 900 | $946.12K | Reduce |
| Q1 2025 | 553.80K | $351.24M | New |
| Q2 2025 | 938.50K | $492.71M | Add |
| Q3 2025 | 926.20K | $520.77M | Reduce |
| Q4 2025 | 604.54K | $466.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on TWO SIGMA ADVISERS, LP
FAQ
How long has TWO SIGMA ADVISERS, LP held REGN?
TWO SIGMA ADVISERS, LP has disclosed REGN holdings in 8 of the last 10 reported quarters, going back to Q3 2023.
What is TWO SIGMA ADVISERS, LP's current position in REGN?
As of Q4 2025, TWO SIGMA ADVISERS, LP holds 604.54K shares of REGN (REGENERON PHARMACEUTICALS), valued at $466.63M, representing 0.91% of its reported portfolio and ranking #22.
Has TWO SIGMA ADVISERS, LP been buying or selling REGN?
In the latest 13F filing (Q4 2025), TWO SIGMA ADVISERS, LP reduced its position in REGN. The position peaked in Q3 2025 at 926.20K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.